J9015 HCPCS Level II code: Injection, aldesleukin, per single use vial
J9015 is the HCPCS code for “Injection, aldesleukin, per single use vial” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9015Injection, aldesleukin, per single use vial
Short description: Aldesleukin injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9015 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1996
Where J9015 sits
- 1J codesDrugs administered other than orally
- 2Active code J9015Injection, aldesleukin, per single use vial
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9015 mean?
J9015 is the HCPCS code for “Injection, aldesleukin, per single use vial” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9015?
CMS lists J9015’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9015
All J codesJ8705Topotecan, oral, 0.25 mgJ8999Prescription drug, oral, chemotherapeutic, nosJ9000Injection, doxorubicin hydrochloride, 10 mgJ9003Leuprolide injectable (camcevi etm), 1 mgJ9010Injection, alemtuzumab, 10 mgJ9011Injection, datopotamab deruxtecan-dlnk, 1 mgJ9017Injection, arsenic trioxide, 1 mgJ9019Injection, asparaginase (erwinaze), 1,000 iuJ9020Injection, asparaginase, not otherwise specified, 10,000 unitsJ9021Injection, asparaginase, recombinant, (rylaze), 0.1 mgJ9022Injection, atezolizumab, 10 mgJ9023Injection, avelumab, 10 mg